Chapter

2. Hyrnuo as a First Treatment for HER2-Mutant Lung Cancer

From 10 Cancer Treatment Approvals From September 2026 and What They Mean for You | CURE by 10 Cancer Treatment Approvals From September 2026 and What They Mean for You

Concepts

  1. Approval

    "Approved: Sept. 9 (accelerated approval) | Read more\n\nHyrnuo (sevabertinib), a pill, can now be used as the first treatment for advanced nonsquamous non-small cell lung cancer with certain HER2 mut

  2. Testing

    "What it means for you: HER2 mutations are found only with biomarker testing of the tumor or blood. If you have advanced lung cancer, make sure that testing was done before starting treatment."

2. Hyrnuo as a First Treatment for HER2-Mutant Lung Cancer | 10 Cancer Treatment Approvals From September 2026 and What They Mean for You | CURE | Bifalgorithm | Bifalgorithm